Principal Financial Group
LUMO

Principal Financial Group’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Principal Financial Group’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-7,676
Closed -$1.67M – 2300
2017
Q1 		$1.67M Hold
7,676
– – ﹤0.01% 1746
2016
Q4 		$710K Buy
7,676
+386
+5% +$43.5K ﹤0.01% 1869
2016
Q3 		$985K Buy
7,290
+90
+1% +$8.94K ﹤0.01% 1774
2016
Q2 		$730K Sell
7,200
-167
-2% -$20.7K ﹤0.01% 1796
2016
Q1 		$1.21M Hold
7,367
– – ﹤0.01% 1704
2015
Q4 		$2.41M Hold
7,367
– – ﹤0.01% 1591
2015
Q3 		$2.38M Buy
7,367
+123
+2% +$54K ﹤0.01% 1600
2015
Q2 		$2.89M Buy
7,244
+588
+9% +$250K ﹤0.01% 1603
2015
Q1 		$3.28M Hold
6,656
– – ﹤0.01% 1535
2014
Q4 		$2.38M Sell
6,656
-333
-5% -$99.1K ﹤0.01% 1649
2014
Q3 		$1.35M Sell
6,989
-55
-0.8% -$12.1K ﹤0.01% 1723
2014
Q2 		$1.68M Sell
7,044
-948
-12% -$193K ﹤0.01% 1717
2014
Q1 		$2.04M Sell
7,992
-230
-3% -$70.3K ﹤0.01% 1650
2013
Q4 		$1.63M Buy
8,222
+133
+2% +$23.7K ﹤0.01% 1705
2013
Q3 		$1.37M Hold
8,089
– – ﹤0.01% 1706
2013
Q2 		$1.44M Buy
+8,089
New +$1.15M ﹤0.01% 1659

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Principal Financial Group's LUMO Position: Q2 2017 in Review

Principal Financial Group sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2017, closing a stake of 7,676 shares — an estimated $1.67M sold.

Principal Financial Group first reported a position in LUMO in Q2 2013 and held it in 16 quarters. The position peaked at $3.28M in Q1 2015. 110 funds tracked by Wall St. Rank hold LUMO as of Q2 2017.

  • Principal Financial Group reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Principal Financial Group sold 7,676 Lumos Pharma, Inc. Common Stock shares in Q2 2017, an estimated $1.67M.
  • Principal Financial Group first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 16 quarters.
  • Principal Financial Group's Lumos Pharma, Inc. Common Stock position peaked at $3.28M in Q1 2015.
  • 110 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2017.

Based on Principal Financial Group's 13F filing for Q2 2017, filed 8 Aug 2017.